JMP Group Announces Addition of Oren Livnat to Equity Research Department
26 März 2014 - 2:00PM
Business Wire
Research Analyst to Cover Specialty
Pharmaceuticals Industry
JMP Group Inc. (NYSE:JMP), an investment banking and alternative
asset management firm, announced today that Oren G. Livnat has
joined JMP Securities as a director and senior research analyst
following the specialty pharmaceuticals industry. Mr. Livnat is
based in the firm’s New York office.
“Oren is well regarded by institutional investors and will be an
important contributor to our healthcare franchise,” said Thomas R.
Wright, director of equities at JMP Securities. “His coverage of
specialty pharmaceuticals will dovetail with JMP’s biotechnology,
medical devices, and life science tools and diagnostics research
and will bring the total number of senior analysts devoted to those
sectors at JMP to six. These areas are highly complex, and JMP
works constantly to provide its brokerage clients with much needed
perspective and actionable insights that can lead to winning
investments in the space.”
Prior to joining JMP Securities, Mr. Livnat spent four years in
equity research at Jefferies & Company, where he covered
development-stage and commercial-stage brand and generic specialty
pharmaceutical companies, with a specific focus on CNS, pain and
specialty generics. Mr. Livnat previously worked in equity research
following specialty pharmaceuticals at Natixis Bleichroeder. Mr.
Livnat received a BA in economics from Wesleyan University and is a
CFA charterholder.
About JMP Group
JMP Group Inc. is an investment banking and asset management
firm that provides investment banking, sales and trading, and
equity research services to corporate and institutional clients and
alternative asset management products to institutional and
high-net-worth investors. JMP Group operates through three
subsidiaries: JMP Securities, Harvest Capital Strategies and JMP
Credit Advisors. For more information, visit www.jmpg.com.
Investor Relations ContactJMP Group Inc.Andrew Palmer,
415-835-8978apalmer@jmpg.comorMedia Relations ContactDukas
Public RelationsSeth Linden, 212-704-7385seth@dukaspr.comZach
Leibowitz, 212-704-7385zach@dukaspr.com
JMP (NYSE:JMP)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
JMP (NYSE:JMP)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über JMP Group LLC (New York Börse): 0 Nachrichtenartikel
Weitere Jmp Grp. News-Artikel